Download PDF
J Reconstr Microsurg 2002; 18(8): 689-696
DOI: 10.1055/s-2002-36501
Copyright © 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Microvascular Protection Induced by Late Preconditioning Was Abolished in STZ-Induced Acute Diabetic Rats

Wei Z. Wang, Seth Jones, Linda L. Stepheson, Kayvan T. Khiabani, William A. Zamboni
  • Division of Plastic Surgery, Department of Surgery, University of Nevada School of Medicine, Las Vegas, NV
Further Information

Publication History

Publication Date:
13 January 2003 (online)

    Permissions and Reprints

ABSTRACT

The authors attempted to determine whether ischemic preconditioning (IPC) can provide microvascular protection in skeletal muscle of diabetic rats against injury from a subsequent (24 hr later) prolonged period of ischemia and reperfusion. Male Sprague Dawley rats weighting 80 to 100 g were injected intraperitoneally with either streptozotocin (STZ, 65 mg/kg) or vehicle (sodium citrate, pH 4.5). Rats with a fasting blood glucose level over 300 mg/dl 1 week after injection of STZ were considered acute diabetic. The cremaster muscle of the rats underwent 45 min of IPC and 24 hr later, 4 hr of warm ischemia followed by reperfusion (I/R). Four groups were compared: IPC in normal rats (n=8); sham IPC in normal rats (n=8); IPC in diabetic rats (n=6); and sham IPC in diabetic rats (n=4). Microvascular responses in the cremaster muscle to IPC were determined by measuring the diameter of feeding, terminal arterioles and capillary perfusion using intravital microscopy, and by the evaluation of the endothelium-dependent nitric oxide system in the terminal arterioles.

The average diameter of the feeding and terminal arterioles, as well as capillary perfusion, were significantly decreased in diabetic animals, compared to normal animals. There was a significant endothelial dysfunction detected in the terminal arterioles of diabetic rats. Ischemic preconditioning provided significant microvascular protection against prolonged ischemia/reperfusion in normal rats, but not in diabetic rats. IPC-induced microvascular protection in the normal skeletal muscle was abolished in STZ-induced acute diabetic rats.

KEYWORD

Ischemic preconditioning - I-R injury - protection - diabetic rat model

REFERENCES

  • 1 Williamson J R, Kilo C, Tilton R G. Mechanisms of glucose- and diabetes-induced vascular dysfunction. In: Ruderman N, Williamson J, Brownlee M, et al (eds). Hyperglycemia, Diabetes, and Vascular Disease Oxford: Oxford University Press 1992: 107-131
    Google Scholar
  • 2 Stehouwer C DA, Lambert J, Donker A JM, Hinsbergh V WM. Endothelial dysfunction and pathogenesis of diabetic angiopathy.  Cardiovas Res . 1997;  34 55-68
    CrossrefPubMedGoogle Scholar
  • 3 Tesfamariam B, Brown M L, Deykin D, Cohen R. Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoid in rabbit aorta.  J Clin Invest . 1990;  85 929-932
    PubMedGoogle Scholar
  • 4 Meraji A, Jayakody L, Senaratne P. Endothelium-dependent relaxation in aorta of BB rats.  Diabetes . 1987;  36 878-881
    PubMedGoogle Scholar
  • 5 Oyama Y, Kawasaki H, Harttori Y, Kanno M. Attenuation of endothelium-dependent relaxation in aorta from diabetic rats.  Eur J Pharmacol . 1986;  132 75-78
    CrossrefPubMedGoogle Scholar
  • 6 Saens D TI, Goldstein I, Azadzol K. Impaired neurogenic and endothelium-dependent relaxation of human penile smooth muscle: the pathophysiological basis for impotence in diabetes mellitus.  N Engl J Med. . 1989;  320 1025-1030
    PubMedGoogle Scholar
  • 7 Brothers T E, Robison J G, Elliott B M. Diabetes mellitus is the major risk factor for African Americans who undergo peripheral bypass graft operation.  J Vasc Surg . 1999;  29 352-359
    PubMedGoogle Scholar
  • 8 Murry C E, Jennings R B, Reimer K A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.  Circulation . 1986;  74 1124-1136
    CrossrefPubMedGoogle Scholar
  • 9 Marber M S, Latchman D S, Walker J M, Yellon D M. Cardiac stress protein elevation 24 hours after brief ischemia or late stress is associated with resistance to myocardial infarction.  Circulation . 1993;  88 1264-1272
    CrossrefPubMedGoogle Scholar
  • 10 Yellon D M, Baxter G F, Garcia-Dorado D. Ischemic preconditionig: present and future directions.  Cardiovasc Res . 1998;  37 21-33
    CrossrefPubMedGoogle Scholar
  • 11 Cohen M V, Liu G S, Downey J M. Preconditioning causes improved wall motion as well as smaller infarcts after transient coronary occlusion in rabbit.  Circulation . 1991;  84 341-349
    PubMedGoogle Scholar
  • 12 Pang C Y, Yang R Z, Zhong A. Acute ischemic preconditioning protects against skeletal muscle infarction in the pig.  Cardiovasc Res . 1995;  29 782-788
    CrossrefPubMedGoogle Scholar
  • 13 Richard V, Kaeffer N, Tron C, Thuillez C. Ischemic preconditioning protects against coronary endothelial dysfunction induced by ischemia and reperfusion.  Circulation . 1994;  89 1254-1261
    PubMedGoogle Scholar
  • 14 Defily D V, Chilian W M. Preconditioning protects cornary microvascular endothelial function.  Am J Physiology . 1993;  265(2 pt 2) H700-6
    PubMedGoogle Scholar
  • 15 Peralta C, Hotter G, Closa D. The protective role of adenosine in inducing nitric oxide synthesis in rat liver ischemia preconditioning is mediated by activation of adenosine A2 receptors.  Hepatology . 1999;  29 126-132
    CrossrefPubMedGoogle Scholar
  • 16 Hotter G, Closa D, Prados M. Intestinal preconditioning is mediated by a transient increase in nitric oxide.  Biochem Biophys Res Commun . 1996;  222 27-32
    CrossrefPubMedGoogle Scholar
  • 17 Wang W Z, Anderson G L, Maldonado C, Barker J. Attenuation of vasospasm and capillary no-reflow by ischemic preconditioning in skeletal muscle.  Microsurgery . 1996;  17 324-329
    CrossrefPubMedGoogle Scholar
  • 18 Wang W Z, Anderson G L, Firrell J C, Tsai T M. Ischemic preconditioning versus intermittent reperfusion to improve blood flow to a vascular isolated skeletal muscle flap of rats.  J Trauma . 1998;  45 953-959
    PubMedGoogle Scholar
  • 19 Wang W Z, Anderson G, Guo S Z. The initiation of microvascular protection by nitric oxide in the late preconditioning phase.  J Reconstr Microsurg . 2000;  16 621-628
    Article in Thieme ConnectPubMedGoogle Scholar
  • 20 Wang W Z, Tsai T M, Anderson G L. Late preconditioning protection is evident in the microcirculation of denervated skeletal muscle.  J Orthop Res . 1999;  17 571-577
    PubMedGoogle Scholar
  • 21 Wang W Z, Anderson G, Guo S Z, Miller F N. The initiating factors of late preconditioning in skeletal muscle.  J Surg Res . 2001;  99 92-99
    CrossrefPubMedGoogle Scholar
  • 22 Wang W Z, Stepheson L L, Anderson G L. Role of PKC in the late phase of microvascular protection induced by preconditioning.  J Surg Res . 2002;  106 166-172
    CrossrefPubMedGoogle Scholar
  • 23 Lee Y H, Wei F C, Lee J, Su M S. Microcirculatory changes following reperfusion insult in diabetic rat skeletal muscles.  Microsurgery . 2000;  20 77-84
    CrossrefPubMedGoogle Scholar
  • 24 Kersten J R, Schmeling T J, Orth K G. Acute hyperglycemia abolishes ischemic preconditioning in vivo.  Am J Physiol Heart Circ Physiol . 1998;  275 H721-H725
    PubMedGoogle Scholar
  • 25 Kersten J R, Toller W G, Gross E R. Diabetes abolishes ischemic preconditioning: role of glucose, insulin, and osmolality.  Am J Physiol Heart Circ Physiol . 2000;  278 H1218-1224
    PubMedGoogle Scholar
  • 26 Panes J, Kurose I, Rodriguez-Vaca D. Diabetes exacerbates inflammatory responses to ischemia-reperfusion.  Circulation . 1996;  93 161-167
    PubMedGoogle Scholar
  • 27 Partamian J O, Bradley R F. Acute myocardial infarction in 258 cases of diabetes.  N Engl J Med . 1965;  273 455-461
    PubMedGoogle Scholar
  • 28 Hokama J Y, Ritter L S, Davis-Gorman G. Diabetes enhances leukocyte accumulation in the coronary microcirculation early in reperfusion following ischemia.  J Diabetes Complication . 2000;  14 96-107
    PubMedGoogle Scholar
  • 29 Salas A, Panes J, Rosenbloom C L. Differential effects of a nitric oxide donor on reperfusion-induced microvascular dysfunction in diabetic and non-diabetic rats.  Diabetologia . 1999;  42 1350-1358
    CrossrefPubMedGoogle Scholar
  • 30 Paulson D J. The diabetic heart is more sensitive to ischemic injury.  Cardiovasc Res . 1997;  34 104-112
    CrossrefPubMedGoogle Scholar
  • 31 Bolli R, Dawn B, Tang X-L. The nitric oxide hypothesis of late preconditioning.  Basic Res Cardiol . 1998;  93 325-339
    CrossrefPubMedGoogle Scholar
  • 32 Jerome S N, Akimitsu T, Gute D, Korthuis R J. Ischemic preconditioning attenuates capillary no-reflow induced by prolonged ischemia and reperfusion.  Am J Physiol. 1995;  268(Heart Circ Physiol 37) H2063-H2067
    PubMedGoogle Scholar
  • 33 Lee H T, Schroeder C A, Shah P M. Preconditioning with ischemia or adenosine protects skeletal muscle from ischemic tissue reperfusion injury.  J Surg Res . 1996;  63 29-34
    CrossrefPubMedGoogle Scholar
  • 34 Menger M D, Rucker M, Vollmar B. Capillary dysfunction in striated muscle ischemia/reperfusion: on the mechanisms of capillary ``no-reflow''.  Shock . 1997;  8 2-7
    CrossrefPubMedGoogle Scholar
  • 35 Ames A, Wright R L, Kowada M. Cerebral ischemia. II. The no-reflow phenomenon.  Am J Pathol . 1968;  52 437-453
    PubMedGoogle Scholar
  • 36 Hardy S C, Homer-Vanniasinkam S, Gough M J. The triphasic pattern of skeletal muscle blood flow in reperfusion injury: an experimental model with implications for surgery on the acutely ischemic lower limb.  Eur Vasc Surg . 1990;  4 587-90
    PubMedGoogle Scholar
  • 37 Korthuis R J, Granger D N, Townsley M I, Taylor A E. The role of oxygen-derived free radicals in ischemia-induced increase in canine skeletal muscle vascular permeability.  Cir Res . 1988;  57 599-609
    PubMedGoogle Scholar
  • 38 Wang W Z, Anderson G L, Firrell J C. Arteriole constriction following ischemia in denervated skeletal muscle.  J Reconstr Microsurg . 1995;  11 99-106
    Article in Thieme ConnectPubMedGoogle Scholar
  • 39 Wang W Z, Anderson G, Fleming J T. Lack of nitric oxide contributes to vasospasm during ischemia/reperfusion injury.  Plast Reconstr Surg . 1997;  99 1099-1108
    PubMedGoogle Scholar
  • 40 Wang W Z, Anderson G, Acland R D, Barker J. Endothelin-1 does not contribute to ischemia/reperfusion-induced vasoconstriction in skeletal muscle.  J Reconstr Microsurg . 1997;  13 439-447
    PubMedGoogle Scholar
  • 41 Wang W Z, Guo S Z, Tsai T M. PAF contributes to vasospasm after prolonged ischemia in skeletal muscle.  J Surg Res . 2000;  89 139-146
    CrossrefPubMedGoogle Scholar
  • 42 Bouchard J F, Lamontagne D. Protection afforded by preconditioning to the diabetic heart against ischemic injury.  Cardiovasc Res . 1998;  37 82-90
    CrossrefPubMedGoogle Scholar
  • 43 Tatsumi T, Matoba S, Kobara M. Energy metabolism after ischemic preconditioning in streptozotocin-induced diabetic rat hearts.  J Am Coll Cardiol . 1998;  31 707-715
    CrossrefPubMedGoogle Scholar
  • 44 Tosaki A, Pali T, Lefaix D. Effects of ginkgo biloba extract and preconditioning on the diabetic rat myocardium.  Diabetologia . 1996;  39 1255-1262
    CrossrefPubMedGoogle Scholar
      >